HR Execs on the Move

STIIIZY

www.stiiizy.com

 
STIIIZY is a cannabis lifestyle brand that offers premium quality cannabis products, including flower, extracts, vapes, pods, and weed delivery.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.stiiizy.com
  • 728 E Commercial Street
    Los Angeles, CA USA 90012
  • Phone: 323.929.4201

Executives

Name Title Contact Details

Similar Companies

Innovacon

Innovacon, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cobb Psychotherapy LCSW

Cobb Psychotherapy is a group private practice providing mental health counseling services. Our therapists practice a range of interventions including evidence-based therapies traditional talk therapy.

Innomar Strategies

Innomar Strategies, a part of AmerisourceBergen, is Canada`s leading patient support provider for specialty pharmaceuticals. We deliver end-to-end support solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient assistance programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies ensures patients are supported throughout their treatment journey every step of the way.

LPT Medical

LPT Medical is your home for all of your respiratory needs from Oxygen Concentrators and CPAP machines to oxygen supply tubing!

Galmed Pharmaceuticals

Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of Aramchol, a novel, once-daily, oral therapy for treating liver diseases utilizing its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or FABACs. Aramchol is initially being developed for treating Non-Alcoholic Steato-hepatitis, or NASH, a chronic disease affecting a large population, for treating patients who also suffer from obesity and insulin resistance. Galmed Pharmaceuticals Galmed’s business has been, in its current legal structure, was incorporated in Israel on July 31, 2013 as a privately held company. However, operating since 2000 under a different group of companies established in the same year. Galmed was co-founded by Professor Tuvia Gilat and Allen Baharaff, based on Professor Gilat’s extensive research in FABAC’s and NASH.